Transporters as Targets for Drugs by Susan NapierTransporters as Targets for Drugs by Susan Napier

Transporters as Targets for Drugs

EditorSusan Napier, Matilda Bingham

Paperback | October 28, 2010

Pricing and Purchase Info

$338.96 online 
$375.95 list price save 9%
Earn 1695 plum® points

In stock online

Ships free on orders over $25

Not available in stores


Transporters are proteins which span the plasma membrane and regulate the traffic of small molecules in and out of the cell. Transporters play a particularly important role in chemical signalling between neurons in the CNS, where they act to control the concentration of neurotransmitters in the synapse. The majority of transporters which are actively being pursued as targets for drug discovery are CNS located and this reflects the history of the field which began with the tricyclic antidepressants (TCAs) over half a century ago. The use of transporter inhibition to regulate the synaptic concentrations of key neurotransmitters is an established approach in the discovery of psychiatric medications. This volume reviews advances in the field of transporters as targets for drug discovery in the last 10 years. The volume will be of interest to scientists engaged in drug research in the pharmaceutical industry, biotech and academia. Following an overview chapter, seven chapters written by leading experts in their area reflect a range of topics pertinent to the transporter field. General topics include recent advances in the structural biology of transporters and its impact on potential structure based drug design and the design of ligands for Positron Emission Tomography and the importance of molecular imaging in understanding early clinical data. Medicinal chemistry approaches are described outlining the discovery of selective serotonin, noradrenaline and dopamine reuptake inhibitors, current efforts towards the discovery of mixed re-uptake inhibitors with varied 'flavours' of monoamine inhibition, advances in the development of inhibitors for the glycine transporter and the discovery of subtype selective EAAT inhibitors. In addition to being an interesting read, the reader will receive a critical overview of progress made in this rapidly developing field.
Title:Transporters as Targets for DrugsFormat:PaperbackDimensions:268 pages, 9.25 × 6.1 × 0 inPublished:October 28, 2010Publisher:Springer Berlin HeidelbergLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:3642099696

ISBN - 13:9783642099694

Look for similar items by category:


Table of Contents

M. Bingham . S. Napier: Overview: Transporters as Targets for Drug DiscoveryI. Sylte . A.W. Ravna . G. Sager . S.G. Dahl: Membrane Transporters: Structure, Function and Targets for Drug DesignG.A. Whitlock . M.D. Andrews . A.D. Brown . P.V Fish . A. Stobie . F. Wakehut: Design of Monoamine Reuptake Inhibitors - SSRIs, SNRIs and NRIsA. Hauck Newman . J.L. Katz: Atypical Dopamine Uptake Inhibitors that Provide Clues About Cocaine's Mechanism at the Dopamine Transporter Z. Chen . J. Yang . P. Skolnick: The Design, Synthesis and Structure-Activity Relationship of Mixed Serotonin, Norepinephrine and Dopamine Uptake InhibitorsG. Antoni . J. Sörensen . H. Hall: Molecular Imaging of Transporters with Positron Emission TomographyR. Bridges . S.A. Patel: Pharmacology of Glutamate Transport in the CNS: Substrates and Inhibitors of Excitatory Amino Acid Transporters (EAATs) and the Glutamate/Cystine Exchanger System xcR. Gilfillan . J. Kerr G. . Walker . G. Wishart: Glycine Transporters and Their Inhibitors